Endurant Capital Management’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,689
Closed -$431K 59
2022
Q1
$431K Sell
3,689
-860
-19% -$142K 0.11% 61
2021
Q4
$1.18M Sell
4,549
-2,951
-39% -$898K 0.28% 55
2021
Q3
$2.05M Sell
7,500
-5,439
-42% -$1.57M 0.47% 41
2021
Q2
$5.53M Sell
12,939
-2,955
-19% -$1.13M 1.52% 27
2021
Q1
$6.12M Buy
+15,894
New +$7.16M 1.6% 27

Other funds holding DRIO

Endurant Capital Management's DRIO Position: Q2 2022 in Review

Endurant Capital Management sold out of DarioHealth (DRIO) in Q2 2022, closing a stake of 3,689 shares — an estimated $431K sold.

Endurant Capital Management first reported a position in DRIO in Q1 2021 and held it in 5 quarters. The position peaked at $6.12M in Q1 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2022.

  • Endurant Capital Management reported no remaining DarioHealth position as of Q2 2022 after selling out during the quarter.
  • Endurant Capital Management sold 3,689 DarioHealth shares in Q2 2022, an estimated $431K.
  • Endurant Capital Management first reported a position in DarioHealth in Q1 2021 and held it in 5 quarters.
  • Endurant Capital Management's DarioHealth position peaked at $6.12M in Q1 2021.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2022.

Based on Endurant Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.